Quarterly report pursuant to Section 13 or 15(d)

Note 2 - Revisions of Previously Issued Financial Statements (Tables)

v3.3.0.814
Note 2 - Revisions of Previously Issued Financial Statements (Tables)
 9 Months Ended
Sep. 27, 2015
Consolidated Statements of Cash Flows [Member]  
Notes Tables  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
Impact on the
Unaudited
Interim Consolidated Statement of Cash Flow
 
In thousands
  
Nine months
ended
September 28, 2014
As
previously filed
    
Adjustment
    
Nine months
ended
September 28, 2014
As
adjusted
  
Net loss
   $ (1,660
)
   $ 210     $ (1,450
)
Items not involving cash:
                        
Depreciation
     3,135       (175
)
     2,960  
Unrealized gain on derivative instruments
     (136
)
     (35
)
     (171
)
Accounts payable (4)
     (3,077 )     12       (3,065
)
Accrued liabilities (4)
     (153
)
     121       (32 )
Cash flow provided by operations
  $ 945     $ 133     $ 1,078  
Cash flow used in investing (4)
   $ (1,151
)
   $ (133 )   $ (1,284
)
Consolidated Statement of Changes in Shareholders Equity [Member]  
Notes Tables  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
Impact on the
Unaudited
Interim Consolidated Statement of Changes in Shareholders’ Equity
 
In thousands
  
September 28, 2014
As
previously filed
    
Adjustment
    
September 28, 2014
As
adjusted
  
Shareholders’ equity – deficit (3)
   $ (234,660
)
   $ (1,508
)
   $ (236,168
)
Consolidated Statements of Operations and Comprehensive Income [Member]  
Notes Tables  
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
Impact on the Unaudited Interim Consolidated
Statements of Operations and Comprehensive Loss
 
In thousands, except per share data
 
  
Three months
ended
September 28, 2014
As
previously filed
    
Adjustment
    
Three months
ended
September 28, 2014
As
adjusted
  
Cost of sales – unrealized loss on derivative instruments (2)
   $ 753     $ 170     $ 923  
Gross profit
     4,734       (170
)
     4,564  
Operating earnings (loss)
     45       (170
)
     (125 )
Net loss and comprehensive loss
   $ (588 )   $ (170
)
   $ (758 )
Basic and diluted loss per share
  $ (0.04 )           $ (0.05 )
Impact on the Unaudited Interim Consolidated
Statements of Operations and Comprehensive Loss
 
In thousands, except per share data
 
  
Nine months
ended
September 28, 2014
As previously filed
    
Adjustment
    
Nine months
ended
September 28, 2014
As adjusted
  
Cost of sales – unrealized gain on derivative instruments (2)
   $ (136
)
   $ (35
)
   $ (171
)
Cost of sales – depreciation (1)
     3,135       (175
)
     2,960  
Gross profit
     14,898       210       15,108  
Operating earnings
     283       210       493  
Net loss and comprehensive loss
   $ (1,660
)
   $ 210     $ (1,450
)
Basic and diluted loss per share
  $ (0.10
)
           $ (0.09
)